Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Central nervous system stimulant effect" refers broadly to the class of pharmacological actions by which drugs and agents increase neuronal activity within the CNS. Such effects are mediated through a variety of mechanisms, most commonly by raising synaptic levels of excitatory neurotransmitters—especially dopamine and norepinephrine—via enhanced release, reuptake inhibition, or receptor activation. This results in increased alertness, attention, and energy, but can also lead to adverse effects like addiction, cardiovascular risk, or psychiatric symptoms. Well-known CNS stimulants include amphetamine, methylphenidate, modafinil, caffeine, cocaine, and others. This term is descriptive of a drug effect, not of a unique molecular entity or actionable drug target.
Elevation of dopamine and norepinephrine in the brain, Blocking dopamine/norepinephrine reuptake, Antagonism of adenosine receptors, Agonism/activation of adrenergic receptors
11 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Central nervous system stimulant effect.